Hestia Insight (Hestia Insight) Accounts Receivable : $0.01 Mil (As of Feb. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Hestia Insight Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Hestia Insight's accounts receivables for the quarter that ended in Feb. 2024 was $0.01 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Hestia Insight's Days Sales Outstanding for the quarter that ended in Feb. 2024 was 19.21.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Hestia Insight's Net-Net Working Capital per share for the quarter that ended in Feb. 2024 was $0.00.

Hestia Insight Accounts Receivable Historical Data

The historical data trend for Hestia Insight's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hestia Insight Accounts Receivable Chart

Hestia Insight Annual Data

Trend

Nov22

Nov23

Accounts Receivable

Hestia Insight Quarterly Data
	Feb22	Aug22	Nov22	Feb23	Aug23	Nov23	Feb24
Accounts Receivable	Get a 7-Day Free Trial			-	-	-	-	0.01

Hestia Insight Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Hestia Insight Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Hestia Insight's Days Sales Outstanding for the quarter that ended in Feb. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.008	/	0.038	*	91
=	19.21

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Hestia Insight's accounts receivable are only considered to be worth 75% of book value:

Hestia Insight's Net-Net Working Capital Per Share for the quarter that ended in Feb. 2024 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0.18	+	0.75 * 0.008	+	0.5 * 0	-	0.061
-	0	-	0)	/	27.9393
=	0.00

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Hestia Insight Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Hestia Insight's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Hestia Insight (Hestia Insight) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Hestia Insight Inc (OTCPK:HSTA) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

400 S. 4th Street, Suite 500, Las Vegas, NV, USA, 89101

Website

http://www.hestiainsight.com

Hestia Insight Inc provides strategic consulting and capital market advisory services for micro, small and medium-sized companies in the healthcare, biotech and fintech sectors. It also provides access to seed capital and mezzanine funding for qualified emerging companies in these industries. The firm derives all of its revenue from consulting services.